Increase in Stress Cardiomyopathy Incidence During the COVID-19 Pandemic
The incidence of stress cardiomyopathy has increased during the COVID-19 pandemic.
The incidence of stress cardiomyopathy has increased during the COVID-19 pandemic.
Electrocardiographic sign of left ventricular hypertrophy was found to predict HF among women.
The USPSTF recommends screening all adults for hypertension with office-based blood pressure measurement.
Greater physical activity may be associated with reduced risk for heart failure in several high-risk subgroups.
An adverse childhood family environment is associated with cardiovascular disease incidence and all-cause mortality later in life.
Cardiorespiratory fitness (CRF) improves mortality risk prediction beyond conventional risk factors.
Cardiac injury is associated with increased mortality in hospitalized patients with coronavirus disease 2019.
Plasma levels of high-sensitivity cardiac troponins can improve the stratification of mortality risk beyond the comorbidity burden in older adults with diabetes.
Though HIPAA regulates how information about patients can be shared, the scope of the policy means that many newer channels fall outside of its purview.
Patients receiving intensive low-density lipoprotein-cholesterol-lowering therapy may have better clinical outcomes when their body mass index is normal vs high.